These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 35090578)

  • 1. Brain macrophages acquire distinct transcriptomes in multiple sclerosis lesions and normal appearing white matter.
    Miedema A; Gerrits E; Brouwer N; Jiang Q; Kracht L; Meijer M; Nutma E; Peferoen-Baert R; Pijnacker ATE; Wesseling EM; Wijering MHC; Gabius HJ; Amor S; Eggen BJL; Kooistra SM
    Acta Neuropathol Commun; 2022 Jan; 10(1):8. PubMed ID: 35090578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcript Profiles of Microglia/Macrophage Cells at the Borders of Chronic Active and Subpial Gray Matter Lesions in Multiple Sclerosis.
    Chomyk A; Kucinski R; Kim J; Christie E; Cyncynatus K; Gossman Z; Chen Z; Richardson B; Cameron M; Turner T; Dutta R; Trapp B
    Ann Neurol; 2024 May; 95(5):907-916. PubMed ID: 38345145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microglia in normal appearing white matter of multiple sclerosis are alerted but immunosuppressed.
    Melief J; Schuurman KG; van de Garde MD; Smolders J; van Eijk M; Hamann J; Huitinga I
    Glia; 2013 Nov; 61(11):1848-61. PubMed ID: 24014207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated microglia do not increase 18 kDa translocator protein (TSPO) expression in the multiple sclerosis brain.
    Nutma E; Gebro E; Marzin MC; van der Valk P; Matthews PM; Owen DR; Amor S
    Glia; 2021 Oct; 69(10):2447-2458. PubMed ID: 34145928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. White matter changes in paediatric multiple sclerosis and monophasic demyelinating disorders.
    Longoni G; Brown RA; MomayyezSiahkal P; Elliott C; Narayanan S; Bar-Or A; Marrie RA; Yeh EA; Filippi M; Banwell B; Arnold DL;
    Brain; 2017 May; 140(5):1300-1315. PubMed ID: 28334875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progranulin expression in brain tissue and cerebrospinal fluid levels in multiple sclerosis.
    Vercellino M; Grifoni S; Romagnolo A; Masera S; Mattioda A; Trebini C; Chiavazza C; Caligiana L; Capello E; Mancardi GL; Giobbe D; Mutani R; Giordana MT; Cavalla P
    Mult Scler; 2011 Oct; 17(10):1194-201. PubMed ID: 21613335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple sclerosis normal-appearing white matter: pathology-imaging correlations.
    Moll NM; Rietsch AM; Thomas S; Ransohoff AJ; Lee JC; Fox R; Chang A; Ransohoff RM; Fisher E
    Ann Neurol; 2011 Nov; 70(5):764-73. PubMed ID: 22162059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased citrullination of histone H3 in multiple sclerosis brain and animal models of demyelination: a role for tumor necrosis factor-induced peptidylarginine deiminase 4 translocation.
    Mastronardi FG; Wood DD; Mei J; Raijmakers R; Tseveleki V; Dosch HM; Probert L; Casaccia-Bonnefil P; Moscarello MA
    J Neurosci; 2006 Nov; 26(44):11387-96. PubMed ID: 17079667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The topograpy of demyelination and neurodegeneration in the multiple sclerosis brain.
    Haider L; Zrzavy T; Hametner S; Höftberger R; Bagnato F; Grabner G; Trattnig S; Pfeifenbring S; Brück W; Lassmann H
    Brain; 2016 Mar; 139(Pt 3):807-15. PubMed ID: 26912645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profiling of the astrocyte transcriptome in multiple sclerosis normal appearing white matter reveals a neuroprotective role.
    Waller R; Woodroofe MN; Wharton SB; Ince PG; Francese S; Heath PR; Cudzich-Madry A; Thomas RH; Rounding N; Sharrack B; Simpson JE
    J Neuroimmunol; 2016 Oct; 299():139-146. PubMed ID: 27725112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal white matter lesions induce long-lasting axonal degeneration, neuroinflammation and behavioral deficits.
    Zhan J; Fegg FN; Kaddatz H; Rühling S; Frenz J; Denecke B; Amor S; Ponsaerts P; Hochstrasser T; Kipp M
    Neurobiol Dis; 2021 Jul; 155():105371. PubMed ID: 33932559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of microglial TMEM119 and P2RY12 immunoreactivity in multiple sclerosis white and grey matter lesions is dependent on their inflammatory environment.
    van Wageningen TA; Vlaar E; Kooij G; Jongenelen CAM; Geurts JJG; van Dam AM
    Acta Neuropathol Commun; 2019 Dec; 7(1):206. PubMed ID: 31829283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microglia and astroglia proliferation within the normal appearing white matter in histologically active and inactive multiple sclerosis.
    Nowacki P; Koziarska D; Masztalewicz M
    Folia Neuropathol; 2019; 57(3):249-257. PubMed ID: 31588711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative texture analysis of brain white matter lesions derived from T2-weighted MR images in MS patients with clinically isolated syndrome.
    Loizou CP; Petroudi S; Seimenis I; Pantziaris M; Pattichis CS
    J Neuroradiol; 2015 Apr; 42(2):99-114. PubMed ID: 24970463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human endogenous retrovirus W in brain lesions: Rationale for targeted therapy in multiple sclerosis.
    van Horssen J; van der Pol S; Nijland P; Amor S; Perron H
    Mult Scler Relat Disord; 2016 Jul; 8():11-8. PubMed ID: 27456869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axonal injury in the cerebral normal-appearing white matter of patients with multiple sclerosis is related to concurrent demyelination in lesions but not to concurrent demyelination in normal-appearing white matter.
    Narayanan S; Francis SJ; Sled JG; Santos AC; Antel S; Levesque I; Brass S; Lapierre Y; Sappey-Marinier D; Pike GB; Arnold DL
    Neuroimage; 2006 Jan; 29(2):637-42. PubMed ID: 16126413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of macrophage inhibitory molecules in multiple sclerosis lesions.
    Koning N; Bö L; Hoek RM; Huitinga I
    Ann Neurol; 2007 Nov; 62(5):504-14. PubMed ID: 17879969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lesion Expansion in Experimental Demyelination Animal Models and Multiple Sclerosis Lesions.
    Große-Veldmann R; Becker B; Amor S; van der Valk P; Beyer C; Kipp M
    Mol Neurobiol; 2016 Sep; 53(7):4905-17. PubMed ID: 26363796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury.
    Fischer MT; Sharma R; Lim JL; Haider L; Frischer JM; Drexhage J; Mahad D; Bradl M; van Horssen J; Lassmann H
    Brain; 2012 Mar; 135(Pt 3):886-99. PubMed ID: 22366799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular signature of different lesion types in the brain white matter of patients with progressive multiple sclerosis.
    Elkjaer ML; Frisch T; Reynolds R; Kacprowski T; Burton M; Kruse TA; Thomassen M; Baumbach J; Illes Z
    Acta Neuropathol Commun; 2019 Dec; 7(1):205. PubMed ID: 31829262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.